Cancer as a Result of Using Zantac

Chappell, Smith & Arden, PA is actively pursuing cases on behalf of clients who may have contracted cancer as a result of using Zantac. On April 1, 2020, the Food and Drug Administration announced an immediate recall of all prescription and over the counter medications containing ranitidine, the active ingredient in Zantac. According to scientific studies, ingestion of ranitidine can lead to exposure to a contaminant known as N-Nitrosodimethylamine (NDMA), which is classified as a probable human carcinogen.

The cancers most commonly linked with the ingestion of Zantac are as follows:

  • Stomach cancer
  • Liver cancer
  • Small intestine cancer
  • Colorectal cancer
  • Bladder cancer
  • Pancreatic cancer
  • Esophageal cancer
  • Kidney cancer
  • Prostate cancer (under the age of 65)
  • Leukemia
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma

Unlike most law firms pursuing these cases, Chappell, Smith & Arden limits its clientele to men and women in the South Carolina area. This allows you to speak with one of our attorneys one-on-one, rather than a nameless “intake specialist” in some far away state. Attorneys Graham Newman and Maggie Chappell will be handling your case should you choose to retain us and both are available to speak to you about your potential case.

Lastly, during the time of the Coronavirus pandemic, our firm has developed the capability to meet with our clients remotely in order to observe social distancing guidelines. There is no need for you to leave the safety of your home for us to begin investigating your case. You may contact us at (803) 929-3600 or at this link and we can walk you through the process of how to begin.